Webinar Overview

The ACC CV Team Section has invited speaker Michael Hoosien, MD, MSc for an educational session on the updated 2023 Atrial Fibrillation Guidelines. In this webinar, Dr. Hoosien will dissect the recommendations that have a high impact on clinical practice.

Key Objectives/Learning Outcomes:
Upon completion of this program, attendees should be able to:

1. Describe the new Atrial Fibrillation classification scheme which is now based on stages of the disease rather than the duration.
2. Recall the new recommendations as they relate to risk factor modification and prevention of thromboembolism.
3. Understand the updated recommendations for left atrial appendage closure and catheter ablation therapy.
4. Describe the new recommendations for rate control and rhythm control.

Webinar Participants

Michael Hoosien, MD MSc, Director Atrial Fibrillation Program, Piedmont Heart Institute
Christopher Walsh, MPAS, PA-C, Advanced Practice Education Program Manager, Piedmont Heart Institute

Credit Information

Joint Accreditation Statement:
In support of improving patient care, the American College of Cardiology Foundation (ACCF) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Disclosure/Conflict of Interest Statement:
As a provider jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), the American College of Cardiology Foundation (ACCF) must ensure balance, independence, objectivity, and scientific rigor in all of their directly provided or jointly provided/co-provided educational activities. Planners, presenters, and other contributors, in a position to control the content are required to disclose to the audience all relevant financial relationships he/she and/or his/her spouse or domestic partner may have, occurring within the past 24 months, with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. When an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, the contributor should disclose that the product is not labeled for the use under discussion or that the product is still investigational.

ACCF is committed to providing its learners with high-quality activities and materials that promote improvements and quality in health care and not a specific proprietary business or commercial interest. The intent of this disclosure is not to prevent participation in educational activities by persons with a financial or other relationship, but rather to provide learners with information on which they can make their own determination whether financial interests or relationships may influence the education activity.

ACCF assesses conflicts of interest (COI) with its faculty, planners, managers, staff, and other individuals who are in a position to control the content of certified activities. All relevant potential conflicts of interest that are identified are thoroughly vetted by course directors, ACCF education staff, and members of the Accreditation Compliance Workgroup (ACWG) through a process that includes appropriate peer review for fair balance, scientific objectivity and validity, and patient care and safety recommendations.

ACCF has taken the necessary steps to ensure that all relevant financial relationships have been mitigated.

Please note ACCF staff and the ACWG members involved with this activity have nothing to disclose.

See Program Committee and Faculty rows below for language communicating disclosure information

Planner/Faculty Disclosure information:
Christopher Walsh, MPAS, PA-C,
Sarah Sloane, PhD, DNP, APRN, FNP-BC, CCRN, CNE
Michael Hoosien, MD MSc